Documentos de Académico
Documentos de Profesional
Documentos de Cultura
16 hipoesplenia
D. Moreno Prez, E. Nez Cuadros, M.J. Vicente Martn,
M. Rivera Cuello, F.J. Garca Martn
Unidad de Infectologa e Inmunodeficiencias. Servicio de Pediatra.
Hospital Materno-Infantil. Complejo Hospitalario Universitario
Carlos Haya. Mlaga
< 2 aos Penicilina V oral 125 mg/12 horas o amoxicilina 10 mg/kg/12 horas
2-12 aos Penicilina V oral 250 mg/12 horas o amoxicilina 250 mg/12 horas
> 12 aos Penicilina V oral 500 mg/12 horas o amoxicilina 250-500 mg/12 horas
in children with asplenia. Infect Dis Clin lactic Penicillin Study II. J Pediatr. 1995;
N Am. 2007; 21: 697-710. 127: 685-90.
2. National Health and Medical Research 10. Ficha tcnica de Synflorix. Disponible en:
Council. Australian Government. Groups http://www.ema.europa.eu/humandocs/PDFs
with special vaccination requirements. In: /EPAR/synflorix/emeacombinedh973es.pdf
The Australian Immunisation Handbook (ltimo acceso: 7 diciembre 2010).
9th Edition. Last update: July 2009. Dis-
11. Ficha tcnica de Prevenar 13. Disponi-
ponible en: http://www.immunise.health.
ble en: http://www.ema.europa.eu/
gov.au (ltimo acceso: 06 diciembre 2010).
humandocs/PDFs/EPAR/Prevenar13/
3. Spelman D, Buttery J, Daley A, Isaacs D, emeacombined-h1104es.pdf (ltimo acce-
Jennens I, Kakakios A, et al. Guidelines so: 07 diciembre 2010).
for the prevention of sepsis in asplenic and
hyposplenic patients. Intern Med J. 2008; 12. Dinleyici EC, Yargic ZA. Current kno-
38: 349-56. wledge regarding the investigational 13-
valent pneumococcal conjugate vaccine.
4. American Academy of Pediatrics, Com- Expert Rev Vaccines. 2009; 8: 977-86.
mittee on Infectious Diseases. Children
with asplenia or functional asplenia. 2009 13. Hanquet G, Kissling E, Fenoll A, Geor-
Report, Red Book. 28th ed. IL, USA: Elk ge R, Lepoutre A, Lernout T, et al. Pedia-
Grove Village; 2009. p. 84-6. tric pneumococcal serotypes in 4 Europe-
an countries. Emerg Infect Dis. 2010; 16:
5. Health Protection Agency. Guidance on
1428-39.
minimising infection in patients with an
absent or dysfunctional spleen. Last upda- 14. Fenoll A, Granizo JJ, Aguilar L, Gimnez
te: 22 october 2009. Disponible en: MJ, Aragoneses-Fenoll L, Hanquet G, et
http://www.hpa.org.uk (ltimo acceso: 06 al. Temporal trends of invasive Strepto-
diciembre 2010). coccus pneumoniae serotypes and antimi-
6. Public Health Agency of Canada. Immu- crobial resistance patterns in Spain from
nization of immunocompromised persons. 1979 to 2007. J Clin Microbiol. 2009; 47:
Canadian Immunization Guide. 7th edi- 1012-20.
tion-2006. Disponible en: http://www. 15. Advisory Committee on Immunization
phac-aspc.gc.ca (ltimo acceso: 06 diciem- Practices (ACIP). Licensure of a 13-valent
bre 2010). pneumococcal conjugate vaccine (PCV13)
7. Infectious Diseases and Immunization and recommendations for use among chil-
Committee, Canadian Paediatric Society. dren. MMWR. 2010; 59: 258-61.
Prevention and therapy o bacterial infec- 16. Actualizacin en vacunacin antineumo-
tions for children with asplenia or hypos- ccica. Recomendaciones del Comit Ase-
plenia. Paediatr Child Health. 1999; 4: sor de Vacunas de la Asociacin Espaola
417-21. de Pediatra. Disponible en: http://www.
8. William BM, Thawani N, Sae-Tia S, vacunasaep.org/recomendaciones_vnc_201.
Corazza GR. Hyposplenism: A compre- htm (ltimo acceso: 6 diciembre 2010).
hensive review. Part II: Clinical manifes- 17. Adamkiewicz TV, Silk BJ, Howgate J,
tations, diagnosis, and management. Baughman W, Strayhorn G, Sullivan K, et
Hematology. 2007; 12: 89-98. al. Effectiveness of the 7-valent pneumo-
9. Falletta JM, Woods GM, Verter JI, et al. coccal conjugate vaccine in children with
Discontinuing penicillin prophylaxis in sickle cell disease in the first decade of
children with sickle cell anemia. Prophy- life. Pediatrics. 2008; 12: 562-9.
Manejo de nios con asplenia/hipoesplenia 157